Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.
about
CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropionAnalysis of NRG 'legal highs' in the UK: identification and formation of novel cathinonesFrom linked open data to molecular interaction: studying selectivity trends for ligands of the human serotonin and dopamine transporterHybrid dopamine uptake blocker-serotonin releaser ligands: a new twist on transporter-focused therapeuticsSynthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.Nicotinic acetylcholine receptor efficacy and pharmacological properties of 3-(substituted phenyl)-2β-substituted tropanes.Bupropion-varenicline interactions and nicotine self-administration behavior in rats.Methamphetamine-like discriminative stimulus effects of bupropion and its two hydroxy metabolites in male rhesus monkeysPharmacological examination of trifluoromethyl ring-substituted methcathinone analogsSimilar activity of mecamylamine stereoisomers in vitro and in vivoDifferential effects of non-nicotine tobacco constituent compounds on nicotine self-administration in ratsCathinone derivatives: a review of their chemistry, pharmacology and toxicology.(±)-2-(N-tert-Butylamino)-3'-[(125)I]-iodo-4'-azidopropiophenone: a dopamine transporter and nicotinic acetylcholine receptor photoaffinity ligand based on bupropion (Wellbutrin, Zyban).Examination of the metabolite hydroxybupropion in the reinforcing and aversive stimulus effects of nicotine in rats.Development of a Rat Plasma and Brain Extracellular Fluid Pharmacokinetic Model for Bupropion and Hydroxybupropion Based on Microdialysis Sampling, and Application to Predict Human Brain Concentrations.
P2860
Q24634660-2F8171AC-D5AF-4F91-8927-A96E5D9D7759Q28249380-DDD8BD2D-BE5F-4D43-B3C6-4B5846D3672CQ28596136-3CC4B5AD-725D-4B8F-A45F-1F32B5E69A57Q33768538-A62BD2A0-FCA7-4F78-A540-B0655C623662Q34164440-8FDA96B7-44D1-4291-A773-B13153C34941Q35089573-96A88C67-4858-4E38-A638-6227D46597AAQ35091751-85D0A797-9055-448B-97A7-5E94D2A24E8FQ36655731-AEE5A717-55D3-4F04-B71E-DB314C978F31Q36851442-A9FDE45E-94A2-47EC-BF0B-D9C626A91215Q37712056-FADE34B1-C07F-4DC2-9058-36047798303FQ37725084-9EEC6078-8280-4270-9DA4-EC3FB214ECD6Q37900939-A26C21FA-72AC-4610-8342-CA3DA41A7B60Q40079534-065A26EE-FF50-4F75-AE8B-A49A0566D05DQ48285456-65CF5326-DD4A-4BAB-A188-8061E5B7F904Q48877772-E59D2289-7851-4E9A-BCE9-6568D8AD22E4
P2860
Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Synthesis and characterization ...... es: aids to smoking cessation.
@ast
Synthesis and characterization ...... es: aids to smoking cessation.
@en
type
label
Synthesis and characterization ...... es: aids to smoking cessation.
@ast
Synthesis and characterization ...... es: aids to smoking cessation.
@en
prefLabel
Synthesis and characterization ...... es: aids to smoking cessation.
@ast
Synthesis and characterization ...... es: aids to smoking cessation.
@en
P2093
P2860
P356
P1476
Synthesis and characterization ...... ues: aids to smoking cessation
@en
P2093
Ana Z Muresan
Bruce E Blough
F Ivy Carroll
Hernán A Navarro
J Brek Eaton
M Imad Damaj
Ronald J Lukas
Syndia K Marxer-Miller
Xiaodong Huang
P2860
P304
P356
10.1021/JM1003232
P407
P577
2010-06-01T00:00:00Z